These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7121468)

  • 1. Biotinylation of human C3.
    Berger M; Gaither TA; Cole RM; Chused TM; Hammer CH; Frank MM
    Mol Immunol; 1982 Jul; 19(7):857-64. PubMed ID: 7121468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth of human malaria parasites in biotinylated erythrocytes.
    Simpson GL; Born JL; Cain G
    Mol Biochem Parasitol; 1981 Dec; 4(5-6):243-53. PubMed ID: 7038477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible biotinylation of C1q with a cleavable biotinyl derivative. Application in C1q receptor (C1qR) purification.
    Ghebrehiwet B; Bossone S; Erdei A; Reid KB
    J Immunol Methods; 1988 Jun; 110(2):251-60. PubMed ID: 3259972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.
    Brown EJ; Joiner KA; Cole RM; Berger M
    Infect Immun; 1983 Jan; 39(1):403-9. PubMed ID: 6822421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptavidin-induced lysis of homologous biotinylated erythrocytes. Evidence against the key role of the avidin charge in complement activation via the alternative pathway.
    Muzykantov VR; Smirnov MD; Samokhin GP
    FEBS Lett; 1991 Mar; 280(1):112-4. PubMed ID: 2009954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of fibronectin with complement component C3.
    Hautanen A; Keski-Oja J
    Scand J Immunol; 1983 Mar; 17(3):225-30. PubMed ID: 6402811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
    Hoya K; Guterman LR; Miskolczi L; Hopkins LN
    Drug Deliv; 2001; 8(4):215-22. PubMed ID: 11757779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
    Baatrup G; Svehag SE; Jensenius JC
    Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
    Garred P; Mollnes TE; Lea T; Fischer E
    Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of C3 conversion by ELISA estimation of neo-determinants on the C3d moiety.
    Holmskov-Nielsen U; Jensenius JC; Teisner B; Erb K
    J Immunol Methods; 1986 Nov; 94(1-2):1-6. PubMed ID: 2431062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avidin-induced lysis of biotinylated erythrocytes by homologous complement via the alternative pathway depends on avidin's ability of multipoint binding with biotinylated membrane.
    Muzykantov VR; Smirnov MD; Samokhin GP
    Biochim Biophys Acta; 1992 Jun; 1107(1):119-25. PubMed ID: 1616915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of complexes between avidin and beta-adrenergic receptors using biotinyl-alprenolol derivatives.
    Meier KE; Ruoho AE
    Biochim Biophys Acta; 1983 Dec; 761(3):257-61. PubMed ID: 6317049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
    Spitzer RE; Stitzel AE; Pauling VL; Davis NC; West CD
    J Exp Med; 1971 Sep; 134(3 Pt 1):656-80. PubMed ID: 15776568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of fragments of the third component of human complement on erythrocytes by a new immunochemical method.
    Szymanski IO; Odgren PR
    Vox Sang; 1984; 46(2):92-101. PubMed ID: 6608178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.